Michael Wolff Jensen

Ascendis Pharma Oncology Division A/S, Ascendis Pharma Oncology Division A/S, ASCENDIS PHARMA A/S, ASCENDIS PHARMA A/S, Ascendis Pharma Europe A/S, ASCENDIS PHARMA BONE DISEASES A/S, ASCENDIS PHARMA BONE DISEASES A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Endocrinology Division A/S and 6 more

Ascendis Pharma Oncology Division A/S, ASCENDIS PHARMA A/S, Ascendis Pharma Europe A/S, ASCENDIS PHARMA BONE DISEASES A/S, Ascendis Pharma Growth Disorders A/S, Ascendis Pharma Endocrinology Division A/S, Ascendis Pharma Nordics A/S, ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S

PARADIS GROUP ApS, PARADIS GROUP ApS, PDK A/S, PARADIS INTERNATIONAL A/S, PARADIS INTERNATIONAL A/S